期刊文献+
共找到12篇文章
< 1 >
每页显示 20 50 100
盐酸托烷司琼联合氟甲强的松龙防治硬膜外吗啡镇痛所致的恶心呕吐
1
作者 张传锋 《美国中华健康卫生杂志》 2004年第3期41-42,共2页
目的 观察盐酸托烷司琼联合氟甲强的松龙预防硬膜外腔应用吗啡术后镇痛引起的恶心呕吐的效果。方法 选择硬膜外麻醉下行下腹部手术的患者122例,手术结束前约30分钟分别给予注射止吐药。5分钟后各组患者均经硬膜外腔注入吗啡2mg进行术... 目的 观察盐酸托烷司琼联合氟甲强的松龙预防硬膜外腔应用吗啡术后镇痛引起的恶心呕吐的效果。方法 选择硬膜外麻醉下行下腹部手术的患者122例,手术结束前约30分钟分别给予注射止吐药。5分钟后各组患者均经硬膜外腔注入吗啡2mg进行术后镇痛,并根据止吐药的不同随机分为4组,Ⅰ组30例,生理盐水2ml;Ⅱ组31例,盐酸托烷司琼5mg+氟甲强的松龙6mg;Ⅲ组30例。盐酸托烷司琼5mg;Ⅳ组31例,氟甲强的松真龙6mg。结果 Ⅱ、Ⅲ、Ⅳ组患者恶心呕吐的发生率均低于Ⅰ组。与Ⅲ、Ⅳ组相比,Ⅱ组患者恶心呕吐的发生率下降更显著。结论 盐酸托烷司琼联合氟甲强的松真龙比单独用盐酸托烷司肤或氟甲强的松真龙更能有效地防治硬膜外吗啡术后镇痛引起的恶心呕吐。 展开更多
关键词 盐酸托烷司琼 联合用药 甲强的松龙 硬膜外镇痛 恶心 呕吐 吗啡
下载PDF
N-乙酰半胱氨酸联合甲基强的松龙治疗放射性肺损伤临床研究 被引量:5
2
作者 曾凡洪 欧阳刚 陈章 《西部医学》 2015年第2期262-264,共3页
目的探讨使用N-乙酰半胱氨酸(NAC)治疗放射性肺损伤的临床效果和应用价值。方法将100例放射性肺损伤患者随机平均分为甲基强的松龙治疗组(对照组)和甲强龙+N-乙酰半胱氨酸治疗组(治疗组),每组50例,疗程14天。4周后观察2组临床疗效。并... 目的探讨使用N-乙酰半胱氨酸(NAC)治疗放射性肺损伤的临床效果和应用价值。方法将100例放射性肺损伤患者随机平均分为甲基强的松龙治疗组(对照组)和甲强龙+N-乙酰半胱氨酸治疗组(治疗组),每组50例,疗程14天。4周后观察2组临床疗效。并分别于第1天和第14天观察血浆TNF-α、IL-6、TGF-β1和CRP水平变化。结果 4周后甲强龙治疗组总有效率为78%,甲强龙+N-乙酰半胱氨酸治疗组为88%,两组间临床疗效的差异有统计学意义(χ2=4.461,P<0.05)。2治疗组在第1天时血浆TNF-α、IL-6、TGF-β1和CRP水平无统计学差异(P均>0.05)。在第14天时,2治疗组血浆TNF-α、IL-6、TGF-β1和CRP水平较前明显下降,各指标差异均有统计学意义(P均<0.05)。同时,与甲强龙治疗组相比甲强龙+N-乙酰半胱氨酸组血浆TNF-α、IL-6、TGF-β1和CRP水平下降更明显,差异均有统计学意义(P均<0.05)。结论本研究发现在常规使用甲强龙治疗的基础上加用N-乙酰半胱氨酸进行辅助治疗,能有效减轻放射性肺损伤的临床症状,同时降低血浆TNF-α、IL-6、TGF-β1和CRP水平。N-乙酰半胱氨酸对于放射性肺损伤有保护作用,可常规应用于临床治疗。 展开更多
关键词 放射性肺损伤 强的松龙(强龙) N-乙酰半胱氨酸
下载PDF
大剂量甲基强的松龙治疗喘息型慢支和支气管哮喘的临床效果
3
作者 李月华 潘祝平 +1 位作者 董利军 孟舒 《上海医药》 CAS 1997年第7期17-18,共2页
喘息型慢支和支气管哮喘在临床上多以反复发作、呼吸困难、肺部可闻及哮鸣音为特征。这类疾病使病人的生活质量受到明显的影响。如何及时、安全、有效地缓解病人的症状,乃是我们广大临床医生共同努力的方向。我科自1996年10~11月应用... 喘息型慢支和支气管哮喘在临床上多以反复发作、呼吸困难、肺部可闻及哮鸣音为特征。这类疾病使病人的生活质量受到明显的影响。如何及时、安全、有效地缓解病人的症状,乃是我们广大临床医生共同努力的方向。我科自1996年10~11月应用大剂量甲基强的松龙治疗喘息型慢支和支气管哮喘共20例,获得满意的效果。现报告如下。 1 对象与方法 1.1 病例选择 喘息型慢支10例,其中男8例,女2例,年龄56~73岁,平均65岁;支气管哮喘10例,其中男7例,女3例。 展开更多
关键词 支气管炎 哮喘 强的松龙 剂量
下载PDF
强的松等治疗242例肾病综合征分析 被引量:2
4
作者 孙晓梅 王宏杰 冯学亮 《西北药学杂志》 CAS 2011年第5期373-374,共2页
目的观察IgA肾病(IgAN)中表现为肾病综合征的患者对强的松等治疗的反应。方法分析肾内科原发IgAN中表现为肾病综合征(NS)的242名病例,注射给予强的松及甲基强的松龙或地塞米松或(和)环磷酰胺冲击治疗,或加用吗替麦考酚酯口服,... 目的观察IgA肾病(IgAN)中表现为肾病综合征的患者对强的松等治疗的反应。方法分析肾内科原发IgAN中表现为肾病综合征(NS)的242名病例,注射给予强的松及甲基强的松龙或地塞米松或(和)环磷酰胺冲击治疗,或加用吗替麦考酚酯口服,部分联合应用ACEI类、ARB类、抗凝药物等综合治疗。结果治疗后尿蛋白降低或转阴,其中病理组织学改变为I~Ⅱ级者疗效更佳。结论强的松等治疗IgAN中表现为肾病综合征疗效确切,值得进一步推广应用。 展开更多
关键词 强的松 甲强的松龙 环磷酰胺 IGA肾病 肾病综合征
下载PDF
大剂量甲泼尼龙对危重特发性血小板减少性紫癜的临床研究 被引量:1
5
作者 李红 董会敏 周洁 《河北医药》 CAS 2013年第11期1688-1689,共2页
特发性血小板减少性紫癜(ITP)是由于免疫机制异常导致血小板破坏过多,从而导致出血性疾病,又称自身免疫性血小板减少性紫癜,临床表现包括外周血小板急剧减少,骨髓巨核细胞正常或增多,血小板更新率加速,从而导致凝血障碍,部分患者无明... 特发性血小板减少性紫癜(ITP)是由于免疫机制异常导致血小板破坏过多,从而导致出血性疾病,又称自身免疫性血小板减少性紫癜,临床表现包括外周血小板急剧减少,骨髓巨核细胞正常或增多,血小板更新率加速,从而导致凝血障碍,部分患者无明显临床症状[1].目前临床通常口服常规剂量泼尼松进行治疗,但常规剂量对危重患者疗效有限,不能及时纠正异常血象,从而无法挽救生命.有研究表明大剂量甲基强的松龙冲击治疗危重患者能大大提高其临床疗效及生存率[2].本研究对常规剂量及大剂量甲泼尼松对重症ITP进行治疗,对我院共收治危重症ITP随机分成2组,对比两种方法的疗效及不良反应,以指导临床. 展开更多
关键词 特发性血小板减少性紫癜 尼龙 沷基强的松龙
下载PDF
酶联免疫吸附法检测牛肝中地塞米松残留量
6
作者 吴娜 《中国畜牧业》 2024年第21期53-54,共2页
地塞米松别名为氟美松、氟甲强的松龙,属于肾上腺皮质激素类药物,具有抗炎、抗过敏和免疫抑制等药理作用,对于类风湿性关节炎、湿疹、哮喘、过敏等疾病,可迅速缓解症状。因其有利于提高饲料转化率,促进畜禽成长,所以在畜牧生产中广泛应用。
关键词 类风湿性关节炎 酶联免疫吸附法 地塞米松 免疫抑制 氟美松 畜牧生产 饲料转化率 甲强的松龙
下载PDF
25例狼疮性肾炎的临床与病理分析
7
作者 张庆红 张建鄂 +1 位作者 李涛 罗昌霞 《临床内科杂志》 CAS 北大核心 2001年第4期310-310,共1页
关键词 狼疮性肾炎 病理学 治疗 强的松龙 强的松 疗效
下载PDF
Effectiveness of Saccharomyces boulardii in a rat model of colitis 被引量:6
8
作者 Mujde Soyturk Saba Mukaddes Saygili +4 位作者 Huseyin Baskin Ozgul Sagol Osman Yilmaz Fatih Saygili Hale Akpinar 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第44期6452-6460,共9页
AIM:To investigate the effects of Saccharomyces boulardii(S.boulardii) in an experimental rat model of trinitrobenzene sulfonic acid(TNBS)-induced colitis.METHODS:Thirty-two Wistar albino female rats were categorized ... AIM:To investigate the effects of Saccharomyces boulardii(S.boulardii) in an experimental rat model of trinitrobenzene sulfonic acid(TNBS)-induced colitis.METHODS:Thirty-two Wistar albino female rats were categorized into five groups.On the first day of the study,50 mg TNBS was administered via a rectal catheter in order to induce colitis in all rats,except those in the control group.For 14 d,the rats were fed a standard diet,without the administration of any additional supplements to either the control or TNBS groups,in addition to 1 mg/kg per day S.boulardii to the S.boulardii group,1 mg/kg per day methyl prednisolone(MP) to the MP group.The animals in the S.boulardii + MP group were coadministered these doses of S.boulardii and MP.During the study,weight loss,stool consistency,and the presence of obvious blood in the stool were evaluated,and the disease activity index(DAI) for colitis was recorded.The intestines were examined and colitis was macro-and microscopically scored.The serum and tissue levels of tumor necrosis factor-α(TNF-α) and nitric oxide(NO) were determined,and fungemia was evaluated in the blood samples.RESULTS:The mean DAI scores for the MP and S.boulardii + MP groups was significantly lower than the TNBS group(3.69 ± 0.61 vs 4.46 ± 0.34,P = 0.018 and 3.77 ± 0.73 vs 4.46 ± 0.34,P = 0.025,respectively).While no significant differences between the TNBS and the S.boulardii or MP groups could be determined in terms of serum NO levels,the level of serum NO in the S.boulardii + MP group was significantly higher than in the TNBS and S.boulardii groups(8.12 ± 4.25 μmol/L vs 3.18 ± 1.19 μmol/L,P = 0.013;8.12 ± 4.25 μmol/L vs 3.47 ± 1.66 μmol/L,P = 0.012,respectively).The tissue NO levels in the S.boulardii,MP and S.boulardii + MP groups were significantly lower than the TNBS group(16.62 ± 2.27 μmol/L vs 29.72 ± 6.10 μmol/L,P = 0.002;14.66 ± 5.18 μmol/Lvs 29.72 ± 6.10 μmol/L,P = 0.003;11.95 ± 2.34 μmol/Lvs 29.72 ± 6.10 μmol/L,P = 0.002,respectively).The tissue NO levels in the S.boulardii,MP and S.boulardii + MP groups were similar.The mean serum and tissue TNF-α levels were determined to be 12.97 ± 18.90 pg/mL and 21.75 ± 15.04 pg/mL in the control group,18.25 ± 15.44 pg/mL and 25.27 ± 11.95 pg/mL in the TNBS group,20.59 ± 16.15 pg/mL and 24.39 ± 13.06 pg/mL in the S.boulardii group,9.05 ± 5.13 pg/mL and 24.46 ± 10.85 pg/mL in the MP group,and 13.95 ± 10.17 pg/mL and 24.26 ± 10.37 pg/mL in the S.boulardii + MP group.Significant differences in terms of the levels of serum and tissue TNF-α and the macroscopic and microscopic scores were not found between the groups.S.boulardii fungemia was not observed in any of the rats.However,Candida fungemia was detected in one rat(14%) in the TNBS group,two rats(28%) in the S.boulardii group,three rats(50%) in the MP group,and three rats(42%) in S.boulardii + MP group.CONCLUSION:S.boulardii does not demonstrate considerable effects on the DAI,pathological scores,or cytokine levels but does decrease the tissue NO levels. 展开更多
关键词 Saccharomyces boulardii RAT Trinitroben-zene sulfonic acid Tumor necrOsis factor-m Nitric ox-ide FUNGEMIA
下载PDF
Atypical presentation of pioderma gangrenosum complicating ulcerative colitis: Rapid disappearance with methylprednisolone 被引量:2
9
作者 Paolo Aseni Stefano Di Sandro +2 位作者 Plamen Mihaylov Luca Lamperti Luciano Gregorio De Carlis 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第35期5471-5473,共3页
Piodermal gangrenosum (PG) is an uncommon ulcerative cutaneous dermatosis associated with a variety of systemic diseases, including inflammatory bowel disease (IBD), arthritis, leukaemia, hepatitis, and primary billia... Piodermal gangrenosum (PG) is an uncommon ulcerative cutaneous dermatosis associated with a variety of systemic diseases, including inflammatory bowel disease (IBD), arthritis, leukaemia, hepatitis, and primary billiary cirrhosis. Other cutaneous ulceration resembling PG had been described in literature. There has been neither laboratory finding nor histological feature diagnostic of PG, and diagnosis of PG is mainly made based on the exclusion criteria. We present here a patient, with ulcerative colitis (UC) who was referred to the emergency section with a large and rapidly evolving cutaneous ulceration. Laboratory and microbiological investigation associated with histological findings of the ulcer specimen allowed us to exclude autoimmune and systemic diseases as well as immuno-proliferative disorders. An atypical presentation of PG with UC was diagnosed. Pulse boluses of i.v. methyl-prednisolone were started, and after tapering steroids, complete resolution of the skin lesion was achieved in 3 wk. The unusual rapid healing of the skin ulceration with steroid mono-therapy and the atypical cutaneous presentation in this patient as well as the risk of misdiagnosis of PG in the clinical practice were discussed. 展开更多
关键词 Ulcerative colitis Pioderma gangrenosum STEROIDS Cutaneous lesion IMMUNOSUPPRESSION
下载PDF
Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: A case report
10
作者 Atsushi Takahashi Yukiko Kanno +7 位作者 Yuta Takahashi Natsumi Sakamoto Kyoko Monoe Hironobu Saito Kazumichi Abe Junko Yokokawa Atsushi Irisawa Hiromasa Ohira 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第35期5474-5477,共4页
A 43-year-old woman with multiple sclerosis (MS) was treated with pulsed methylprednisolone and interferon 13 at a hospital. Four weeks after initiating treatment, liver dysfunction occurred and she was referred and... A 43-year-old woman with multiple sclerosis (MS) was treated with pulsed methylprednisolone and interferon 13 at a hospital. Four weeks after initiating treatment, liver dysfunction occurred and she was referred and admitted to our hospital. Clinical and laboratory findings were consistent with and fulfilled the criteria for drug-induced hepatitis, but not for autoimmune hepatitis (AIH). She was successfully treated with corticosteroids. As ataxia developed after i year, she was treated with pulsed methylprednisolone for 3 days, then readmitted to our hospital when liver dysfunction occurred. Clinical and laboratory findings led to the diagnosis of AIH. To the best of our knowledge, this is the second case of AIH developed after pulsed methylprednisolone for MS. 展开更多
关键词 Multiple sclerosis Autoimmune hepatitis Pulsed methylprednisolone
下载PDF
Might liver transplantation recipients with primary hepatocellular carcinoma benefit from GVT effect of aGVHD?
11
作者 Sen Xie Ligong Tang +3 位作者 Xiong Cai Zhixiong Li Huanhuan Chen Hui Bao 《The Chinese-German Journal of Clinical Oncology》 CAS 2014年第11期535-538,共4页
We aimed to access if acute graft-versus-host disease (aGVHD) in liver transplantation recipients of hepatocellular carcinoma (HCC) might develop a graft-versus-tumor effect (GVT) other than immunological damage... We aimed to access if acute graft-versus-host disease (aGVHD) in liver transplantation recipients of hepatocellular carcinoma (HCC) might develop a graft-versus-tumor effect (GVT) other than immunological damage which would benefit prophylaxis of tumor recurrence. Methods: Dynamic observation of 3 cases of liver transplantation recipients of HCC and cirrhosis, which developed manifestations of fever, skin rash, watery diarrhea, pancytopenia and were finally diagnosed as aGVHD. Two of which got recovered from intravenously pulse methylprednisolone, high-dose intravenous immunoglobulin, antibiotics administration simultaneously and promptly withdrawal of oral immunosuppressants. Two survivors were follow-up regularly with biological monitoring and imaging surveillance for tumor recurrence thereafter. Results: Two recipients survived healthily with stable liver graft function and normal serum AFP level and blood routine test. No sign of tumor recurrence was found in repeat imaging examinations for liver graft, lung, brain and other tissue or organs within a period of 96 months and 17 months to date, respectively. Conclusien: Despite of the fatal damage to according organs and tissue, it suggest that aGVHD in liver recipients of HCC may also develop a GVT effect and benefit prophylaxis of tumor recurrence and result in a long-term healthy recipients survival. 展开更多
关键词 hepatocellular carcinoma (HCC) liver transplantation acute graft versus host disease graft versus tumor
下载PDF
Effect of methylprednisolone on reperfusion injury in severe uncontrolled hemorrhagic shock
12
作者 夏芳 曹经山 +3 位作者 詹丽英 夏中元 夏正远 黄海波 《Chinese Journal of Traumatology》 CAS 2003年第6期359-362,共4页
Objective: To study the effect of methylprednisolone (MP) on reperfusion injury in severe uncontrolled hemorrhagic shock and explore the possible mechanism involved. Methods: Twelve dogs were randomly divided into two... Objective: To study the effect of methylprednisolone (MP) on reperfusion injury in severe uncontrolled hemorrhagic shock and explore the possible mechanism involved. Methods: Twelve dogs were randomly divided into two groups, control group (Group I, n=6) and MP group (Group II, n=6). The animals were bled continuously from a femoral artery catheter to produce uncontrolled hemorrhagic shock models. Resuscitation with lactated Ringer’s (LR) solution was initiated when mean arterial pressure (MAP) decreased to 20 mm Hg, and MAP was maintained at 30-40 mm Hg. MP (4 mg/kg) was injected intravenously in Group II when resuscitation began. While in Group I, normal saline (NS) was injected instead. The levels of superoxide dismutase (SOD) and malondialdehyde (MDA) were measured before exsanguination (T 1), when MAP decreased to 20 mm Hg (T 2), 60 min (T 3) and 120 min (T 4) after resuscitation. Heart rate, MAP and cardiac output (CO) levels were recorded concomitantly. Results: Infusion volume and hemorrhage volume shed from the superior mesenteric artery in Group I were higher than those in Group II (P< 0.01 and P< 0.05). After reperfusion, blood SOD levels decreased progressively and MDA levels increased rapidly in Group I. In Group II, blood SOD levels at T 3 and T 4 decreased as compared with that at T 1 but a stepwise increase was present. At T 4, blood SOD level was significantly higher in Group II than in Group I (P< 0.01). At T 3 and T 4, MDA levels were markedly lower in Group II than in Group I. During reperfusion, MAP was more steady in Group II than in Group I and survival rate after 120 min (at T 4) was higher in Group II than in Group I (P< 0.05). Conclusions: MP has a protective effect on severe uncontrolled hemorrhagic shock and subsequent reperfusion injury. The mechanism mainly involves the anti-lipid peroxidation activity of MP. 展开更多
关键词 METHYLPREDNISOLONE Reperfusion injury Lipid peroxidation Shock hemorrhagic
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部